IVF PulseFree Second Opinion

Independent review of an IVF cycle

Should I get a second opinion after a failed IVF cycle?

The short answer

A useful second opinion is a close reading of your records, not a fresh start. The reviewer checks stimulation, trigger, egg, fertilisation and blastocyst numbers against lab benchmarks such as the 2017 Vienna consensus, then embryo grades, transfer notes and lining thickness 1,4. In India, the 2002 medical ethics regulations require requested records to be issued within 72 hours 5.

After a failed cycle it is hard to tell what was bad luck and what could have gone differently. A second opinion is one way to find out, but only if the person reviewing has the right documents and knows what to compare them with.

This page sets out what a reviewer looks at in each report, which benchmarks apply and where they don't, which documents to collect, and what Indian regulations say about getting your records. It also covers when a second opinion adds most, and how staying and switching clinics compare.

Reading your report

Stimulation chart
The day-by-day record of injections, doses and scan measurements of each follicle during stimulation.
Trigger
The injection that completes egg maturation before egg collection. The chart should show the drug, the time it was given and the follicle sizes that day.
OPU / oocyte pick-up
Egg collection. The report gives the number of eggs retrieved.
MII
Mature eggs. Only these can be injected in ICSI.
2PN
The day-1 sign that an egg fertilised normally.
Blastocyst grade
A short code describing a day-5 or day-6 embryo: its fluid-filled cavity and the quality of its inner cell mass and outer layer (trophectoderm) 1.
Endometrial thickness
The lining measured on scan, in millimetres, before transfer.

What does a second-opinion reviewer actually look at in the cycle reports?

A careful review goes through the cycle in order and asks, at each step, whether the numbers are what that stage should produce for someone of your age and ovarian reserve. The benchmarks most often used for the laboratory steps come from the 2017 Vienna consensus of ESHRE and ALPHA Scientists in Reproductive Medicine 1.

  • Stimulation chart: the protocol, starting dose, any mid-cycle dose changes and how the follicles grew. ESHRE's 2025 guideline says changing the dose mid-stimulation is probably not recommended, so repeated changes are worth asking about 3.
  • Trigger: the drug and the timing. ESHRE notes that most clinics trigger when several leading follicles are 16–22 mm, and advises against timing the trigger on oestradiol levels alone 3.
  • Progesterone on trigger day: for a planned fresh transfer, ESHRE 2025 says measuring it is probably recommended; if it is high, lower pregnancy chances should be discussed 3.
  • Eggs collected against follicles: the Vienna reference range is 80–95% of the follicles measured on trigger day 1.
  • Mature eggs: the Vienna reference range is 75–90% of eggs retrieved being mature (MII) at ICSI 1.
  • Fertilisation: for ICSI, the competency value is at least 65% of mature eggs injected, with a benchmark of at least 80%; for conventional IVF, at least 60% and 75% of eggs inseminated 1.
  • Blastocysts: the competency value is at least 40% of normally fertilised eggs reaching blastocyst on day 5, with a benchmark of at least 60% 1.
  • Embryo grades: which grading system the lab used and what each grade means. The Istanbul consensus was written to standardise how labs describe embryos, because terms were not consistent 2.
  • Transfer notes: how many embryos were transferred, at what stage, fresh or frozen, and whether the transfer was difficult. The ART (Regulation) Act, 2021 allows no more than three embryos in a cycle 7.
  • Endometrial thickness: ESHRE's implantation-failure group cites a meta-analysis in which a lining under 7 mm in fresh cycles was linked to lower live birth (odds ratio 0.47), while noting the link weakens after adjusting for other factors 4.

Can one cycle fall below a benchmark without anyone being at fault?

Yes. The Vienna figures are laboratory-level indicators, calculated across a reference group of patients: women under 40 using their own fresh eggs and ejaculated sperm, without embryo testing 1. The consensus itself says the values are mainly based on expert opinion 1. One woman's cycle is a single draw from that spread, and her eggs may not resemble the reference group.

What a benchmark can do is point to the right question. A fertilisation rate far below the competency value is a reason to ask the lab about egg maturity, sperm preparation and technique. It is not, on its own, proof of an error. A pattern across more than one cycle, or the lab's own figures for patients like you, tells you more 1.

Which documents should you gather before a second opinion?

Ask for copies, not summaries, wherever you can. A reviewer working from a one-page discharge note can say far less than one who has the embryology sheets.

  • Pre-treatment tests: AMH or antral follicle count, hormone results, scans, semen analysis reports, and any earlier hysteroscopy or HSG reports.
  • The stimulation chart: drug names, doses by day, scan measurements and blood test results.
  • The trigger record: drug, dose, date and time.
  • The egg collection report: eggs retrieved and how many were mature.
  • The embryology report: fertilisation check on day 1, cell counts and grades by day, the grading system used, and which embryos were frozen.
  • The transfer note: number, stage and grade of embryos transferred, endometrial thickness, and any comment on difficulty.
  • Beta hCG results and early scan reports, if any.
  • The discharge certificate, which the ART Act requires clinics to issue with details of the procedure performed 7.
  • Your consent forms and an itemised bill, so any add-ons used are on record.

Can the clinic refuse to give you your records?

The Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002 require that when a patient or authorised attendant asks for medical records, the request be acknowledged and the documents issued within 72 hours (regulation 1.3.2) 5. The same regulations require doctors to keep indoor-patient records for three years from the start of treatment (regulation 1.3.1) 5.

The National Medical Commission published replacement professional-conduct regulations in August 2023 6. Its website lists a later August 2023 notification keeping them in abeyance, and it continues to host the 2002 regulations 5,6.

Separately, the ART (Regulation) Act, 2021 requires every ART clinic to issue a discharge certificate with details of the procedure performed (section 21(h)) and to run a grievance cell (section 21(f)) 7. A written, dated request is the simplest way to show when you asked.

When is a second opinion most useful?

Not every failed cycle needs one. A single transfer that did not work is often chance, and ESHRE's 2023 recommendations suggest investigating only once the embryos transferred carried a cumulative predicted chance of implantation above 60% 4. A second opinion earns its cost in more specific situations.

  • When enough good embryos have been transferred to pass ESHRE's 60% threshold without implantation 4.
  • When a number in your reports sits far outside the Vienna ranges, such as fertilisation or blastocyst rates well below the competency values 1.
  • When the plan for the next cycle is the same protocol, with no explanation of what the first cycle showed.
  • When you are offered add-ons that ESHRE does not recommend, such as NK cell testing or endometrial receptivity tests 9. The HFEA advises asking why an add-on is being offered and whether it may benefit you specifically 8.
  • After fertilisation failure, to discuss whether artificial oocyte activation applies; ESHRE recommends it only after 0% or under 30% fertilisation, or globozoospermia 9.
  • Before a large step such as moving to donor eggs, which ESHRE's implantation-failure group mentions as an option but says still needs studies to confirm its benefit after repeated failure 4.

What can a second opinion not tell you?

A review works from what was written down. It cannot re-examine embryos that have already been transferred or discarded, and a grade on paper carries less information than the embryologist saw under the microscope. It cannot examine you, and it cannot promise that a different plan would have worked.

It also cannot replace the conversation with your treating doctor. The most useful outcome is often a short list of specific questions to take back to your clinic.

It depends on…

Has this cycle been explained to you, stage by stage?

Yes, and the next plan changes something specific

A second opinion is optional. Keep copies of your records anyway.

Yes, but the plan is the same again

A review is reasonable. Ask what the first cycle showed and what will be different.

No clear explanation

Request your records in writing; the 2002 regulations require them within 72 hours 5.

How many good-quality embryos have been transferred without implantation?

Not enough to reach a 60% cumulative predicted chance 4

Chance is the likelier explanation. A review can confirm the cycle went as expected 4.

Enough to pass 60% 4

ESHRE suggests counselling on further investigation. This is where an outside review adds most 4.

Have you been offered new tests or add-ons?

Yes: NK cell tests, ERA or immune treatments

ESHRE 2023 does not recommend these 9. Consider a review before paying for them.

Yes: tests ESHRE supports for your situation

Ask what result would change the next cycle 4.

No

Ask your clinic what, if anything, it would change next time.

Staying with your clinic or switching after a failed cycle

StayingSwitching
Knowledge of your last cycleYour team saw your response first-handWorks from your records, so it depends on how complete they are
Changing the planAsk what specifically will differ next timeA new team may try a different approach; different is not automatically better
Lab performanceAsk for the lab's own fertilisation and blastocyst ratesAsk the new lab the same questions and compare with the Vienna ranges 1
Frozen embryosStay where they areAsk both clinics how embryos are transferred between labs, and the cost
Earlier testsUsually carried overSome may be repeated; bringing every report limits this
RegistrationThe ART Act requires every ART clinic to be registered 7Check the new centre's registration under the same Act 7

What's worth checking

  • Request your full records in writing and keep a dated copy; the 2002 regulations set a 72-hour window 5.
  • Check the stimulation chart for dose changes and follicle sizes at trigger 3.
  • Compare mature eggs with eggs collected against the Vienna 75–90% range 1.
  • Compare fertilisation per mature egg injected with the Vienna ICSI competency value of 65% 1.
  • Compare blastocysts per fertilised egg with the Vienna day-5 competency value of 40% 1.
  • Note the grading system used for your embryos 2.
  • Note endometrial thickness on the transfer note 4.
  • Ask for the discharge certificate the ART Act requires 7.

Questions to ask your doctor

  1. Can I have complete copies of my stimulation chart, embryology report and transfer note?
  2. How did my fertilisation and blastocyst numbers compare with your lab's usual rates for women my age?
  3. Which grading system does your lab use, and what did my embryos' grades mean?
  4. Was progesterone measured on trigger day, and did it affect the decision to transfer fresh?
  5. What would you change in the next cycle, and why?
  6. Would you be comfortable with me getting an outside review of these records?

Questions people ask

Is it wrong to ask for a second opinion from another IVF doctor?

No. The 2002 ethics regulations state that in every consultation the benefit to the patient is of foremost importance, and that where consulting doctors cannot agree, the situation should be explained frankly and the patient may seek further advice 5.

How long must an IVF clinic keep my records?

The 2002 regulations require doctors to keep indoor-patient records for three years from the start of treatment 5. The ART (Regulation) Act, 2021 separately requires clinics to keep detailed records of donor eggs, sperm and embryos, used or unused, for at least ten years 7.

Can a second opinion be done from reports alone, without visiting?

A records review can check the numbers, timing and notes against benchmarks, which is most of what a second opinion does. It cannot examine you or look at the embryos, so any suggestion to change treatment still needs to go through a doctor who can.

Do I have to tell my current doctor I am taking a second opinion?

No rule requires it. The 2002 regulations say a physician who has taken on a case should not withdraw without adequate notice, and that where there is irreconcilable difference of opinion the circumstances should be explained frankly and the patient is free to seek further advice 5. Your treatment information is confidential under the ART Act and is not passed to another clinic unless you pass it 7.

My clinic gave me only a discharge summary, not the embryology sheets. What can I do?

Ask again in writing, naming each document: the stimulation chart, the day-1 fertilisation check, the embryology report with grades by day, and the transfer note. Regulation 1.3.2 covers medical records requested by a patient or authorised attendant, to be issued within 72 hours 5. The ART Act separately requires a discharge certificate and obliges every clinic to run a grievance cell 7.

We never got a discharge certificate. Can we still ask for one?

Yes. Section 21(h) of the ART (Regulation) Act, 2021 makes it a duty of the clinic to issue a discharge certificate stating details of the procedure performed, and we found no deadline in the Act for requesting it 7. It is not a substitute for the full records, because it states what was done rather than the day-by-day numbers a reviewer reads.

How do I know a second opinion is not just a sales pitch for more treatment?

Judge it by what it rules out. The HFEA advises asking why any add-on is offered and whether it may benefit you specifically 8, and ESHRE's 2023 recommendations list several popular extras — immune tests and treatments, endometrial receptivity testing, sperm DNA damage testing — as not recommended for routine clinical use 9. A review that proposes a bundle of them is worth questioning.

Can anyone tell me what my chances are in the next cycle?

Only as an estimate. A UK model built from 113,873 women's records puts figures on it: a 30-year-old with two years of unexplained primary infertility had a 46% chance of live birth from the first complete cycle and 79% over three 10. After a first cycle giving five eggs and one cleavage-stage transfer with none frozen, those became 28% and 56% 10. The data are from 1999–2008 UK treatment.

How many embryos can be transferred at one time in India?

Not more than three oocytes or embryos may be placed in the uterus during a treatment cycle, under section 24(b) of the ART (Regulation) Act, 2021 7. More is not better: the HFEA warns that multiple births can seriously harm mother and babies, that at least half of twins are born premature and underweight, and that single embryo transfer has no significant impact on success rates 11.

What if the review finds nothing was done wrong?

That is a result, not a wasted fee. ESHRE suggests investigating failed transfers only once the embryos transferred carried a cumulative predicted chance of implantation above 60%, because below that, chance is the likelier explanation 4. In the UK model, live birth accumulates across attempts: 29.1% of women had a baby after the first complete cycle and 43.0% after six 10.

Will getting a second opinion delay my next cycle?

It need not. Requested records are to be issued within 72 hours 5, and a records review can run while your own clinic's review appointment is being arranged. The real question is whether the next transfer is the reasonable next step or the point at which investigation is due, which ESHRE frames by how many good embryos have already been transferred 4.

Should I ask for photos or time-lapse images of my embryos?

You can ask, but they add less than the numbers do. A reviewer works from the grades, the grading system the lab used and the day each embryo reached each stage 1,2. ESHRE's add-ons group found no clear difference in live birth between time-lapse incubation and conventional incubation, so not every lab records images, and their absence is not a gap in your care 9.

Sources

  1. ESHRE Special Interest Group of Embryology and Alpha Scientists in Reproductive Medicine. The Vienna consensus: report of an expert meeting on the development of ART laboratory performance indicators. Hum Reprod Open. 2017;2017(2):hox011. ESHRE / ALPHA / Human Reproduction Open
  2. ALPHA Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology. Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting. Reprod Biomed Online. 2011;22(6):632–646. ALPHA / ESHRE / Reproductive BioMedicine Online
  3. ESHRE Guideline Group on Ovarian Stimulation; Ata B, Bosch E, Broer S, Griesinger G, Grynberg M, et al. ESHRE guideline: ovarian stimulation for IVF/ICSI: an update in 2025. Hum Reprod. 2026;41(4):498–514. ESHRE / Human Reproduction
  4. ESHRE Working Group on Recurrent Implantation Failure; Cimadomo D, de los Santos MJ, Griesinger G, Lainas G, Le Clef N, et al. ESHRE good practice recommendations on recurrent implantation failure. Hum Reprod Open. 2023;2023(3):hoad023. ESHRE / Human Reproduction Open
  5. Medical Council of India. Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002 (as amended up to 8 October 2016), regulations 1.3.1, 1.3.2, 2.4, 3.2 and 3.4.2. Medical Council of India, hosted by the National Medical Commission
  6. National Medical Commission. Rules and Regulations, NMC: Registered Medical Practitioner (Professional Conduct) Regulations, 2023 (2 August 2023) and amendment notification of 23 August 2023 keeping them in abeyance. National Medical Commission
  7. The Assisted Reproductive Technology (Regulation) Act, 2021 (No. 42 of 2021), sections 15, 21, 23 and 24. Gazette of India Extraordinary, 18 December 2021. Government of India (Gazette of India)
  8. Human Fertilisation and Embryology Authority. Treatment add-ons with limited evidence. HFEA (UK regulator)
  9. ESHRE Add-ons working group; Lundin K, Bentzen JG, Bozdag G, Ebner T, Harper J, et al. Good practice recommendations on add-ons in reproductive medicine. Hum Reprod. 2023;38(11):2062–2104. ESHRE / Human Reproduction
  10. McLernon DJ, Steyerberg EW, te Velde ER, Lee AJ, Bhattacharya S. Predicting the chances of a live birth after one or more complete cycles of in vitro fertilisation: population based study of linked cycle data from 113 873 women. BMJ. 2016;355:i5735. BMJ
  11. Human Fertilisation and Embryology Authority. Risks of fertility treatment: multiple births. HFEA (UK regulator)

Tools for this step

WhatsApp us